Conference abstractPublished 14 Jan 2022
Is low-intensity extracorporeal shockwave therapy more effective at improving IIEF-EF score compared to traditional PDE5 inhibitor therapy in the treatment of men with vasogenic erectile dysfunction?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The occurrence of vasogenic erectile dysfunction is strongly correlated to cardiovascular diseases (CVD). PDE5 inhibitors are currently first-line therapy. However, combined use with nitroglycerine, a key therapy in acute coronary syndrome, is contraindicated. The clinical prevalence of CVD with secondary erectile dysfunction necessitate research for alternative therapies. Purpose: The purpose of this research was to compare the safety and efficacy of current first-line therapy to novel therapy LiESWT in the treatment of vasculogenic erectile dysfunction. Materials and Methods: Research was conducted using the following: Ovid, PubMed, and Google Scholar. Keywords searched were “Erectile dysfunction”, “Extracorporeal shockwave therapy”, “Erectile function”, “IIEF”, and “Phosphodiesterase 5”. The inclusion criteria included men receiving treatment for ED and excluded meta-analyses or systematic review study designs. Twenty articles met the inclusion criteria. Population groups mainly consisted of men with ED
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Reproductive Health and Contraception
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Jesus Ibarra”
